Joy Liu Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 7 hours ago
Joy Liu has an estimated net worth of at least $11.8 million*, as of May 20, 2026. They own 20,729 shares of VRTX stock. They have sold 7,920 shares of VRTX stock since 2021, for an estimated $2.8 million.
Joy Liu $VRTX SEC Form 4 Insider Trading
Joy Liu has filed a total of 20 insider trades in $VRTX since 2021. Their most recent trade was a sale of 1,104 shares, made on May 01, 2026. Their largest trade was a sale of 1,743 shares, made on Aug 15, 2022. We estimate that they now own 20,729 shares of $VRTX, worth an estimated $9.0 million.
Insider Trading at $VRTX
There have been a total of 569 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 33 shares reported by Mark E. Bunnage (EVP, Chief Scientific Officer), made on May 15, 2026.
History of Insider Stock Trades by Joy Liu
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 1,104 | May 01, 2026 | May 5, 2026, 5:11 p.m. |
|
VRTX
|
Sale | 978 | Apr 01, 2026 | April 3, 2026, 4:53 p.m. |
|
VRTX
|
Sale | 892 | Mar 02, 2026 | March 4, 2026, 5:21 p.m. |
|
VRTX
|
Sale | 206 | Aug 15, 2022 | Aug. 17, 2022, 5:36 p.m. |
|
VRTX
|
Sale | 698 | Aug 15, 2022 | Aug. 17, 2022, 5:36 p.m. |
|
VRTX
|
Sale | 100 | Aug 15, 2022 | Aug. 17, 2022, 5:36 p.m. |
|
VRTX
|
Sale | 700 | Aug 15, 2022 | Aug. 17, 2022, 5:36 p.m. |
|
VRTX
|
Sale | 1,743 | Aug 15, 2022 | Aug. 17, 2022, 5:36 p.m. |
|
VRTX
|
Sale | 300 | Aug 15, 2022 | Aug. 17, 2022, 5:36 p.m. |
|
VRTX
|
Sale | 946 | Aug 09, 2022 | Aug. 10, 2022, 4:06 p.m. |
|
VRTX
|
Sale | 25 | May 16, 2022 | May 17, 2022, 8 p.m. |
|
VRTX
|
Sale | 19 | May 16, 2022 | May 17, 2022, 8 p.m. |
|
VRTX
|
Sale | 20 | May 16, 2022 | May 17, 2022, 8 p.m. |
|
VRTX
|
Sale | 34 | May 16, 2022 | May 17, 2022, 8 p.m. |
|
VRTX
|
Sale | 35 | May 16, 2022 | May 17, 2022, 8 p.m. |
|
VRTX
|
Sale | 41 | Apr 29, 2022 | May 3, 2022, 4:28 p.m. |
|
VRTX
|
Sale | 30 | Apr 29, 2022 | May 3, 2022, 4:28 p.m. |
|
VRTX
|
Sale | 22 | Apr 29, 2022 | May 3, 2022, 4:28 p.m. |
|
VRTX
|
Sale | 10 | Apr 29, 2022 | May 3, 2022, 4:28 p.m. |
|
VRTX
|
Sale | 17 | Apr 29, 2022 | May 3, 2022, 4:28 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Stuart A Arbuckle, EVP, COO
-
Jeffrey M Leiden, Executive Chairman
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Carmen Bozic, EVP and CMO
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
-
Mark E. Bunnage, EVP, Chief Scientific Officer
-
Duncan Mckechnie, EVP, Chief Commercial Officer
-
Joy Liu, EVP and Chief Legal Officer
-
Amit Sachdev, EVP, Chief Patient Officer
-
Charles F Jr Wagner, EVP, CO & FO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.